Glecaprevir
Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM[2].
Product Specifications
CAS Number
1365970-03-1
Product Name Alternative
ABT-493
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HCV; HCV Protease; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Glecaprevir.html
Purity
99.93
Solubility
DMSO : ≥ 83.3 mg/mL
Smiles
O=C([C@H]1N(C([C@@H](NC(O[C@@]2([H])[C@@]3([H])CCC2)=O)C(C)(C)C)=O)C[C@@](OC4=NC5=CC=CC=C5N=C4C(F)(/C=C/CO3)F)([H])C1)N[C@]6([C@H](C(F)F)C6)C(NS(=O)(C7(CC7)C)=O)=O
Molecular Formula
C38H46F4N6O9S
Molecular Weight
838.87
Precautions
H302, H315, H319, H335
References & Citations
[1]Ng TI, et al. In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir. Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01620-17.|[2]Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG238289 10 µg
C1orf38 (THEMIS2) (NM_001286115) Human Tagged ORF Clone
Sign In for Pricing
View Details 
LY400146 100 µg
Amylin (IAPP) (NM_000415) Human Over-expression Lysate
Sign In for Pricing
View Details 
![Dibenz[b,e]oxepin-11(6H)-one](https://cdn.genprice.uk/products/572/4486894532231/imageurl/trc-d416925-1g.webp)